scholarly journals Comparative Efficacy of Bispectral Index Monitoring and Clinical Assessment in The Recovery of Patients Undergoing Open Renal Surgery: A Randomized, Double-Blind Study

2016 ◽  
Vol 1 (1) ◽  
Author(s):  
Hossein Khoshrang ◽  
Maryam Nemati ◽  
Gholamreza Mokhtari ◽  
Farshid Pourreza ◽  
Zahra Atrkar Roshan ◽  
...  
Keyword(s):  
Clinical Assessment ◽  
Bispectral Index ◽  
Blind Study ◽  
Double Blind Study ◽  
Comparative Efficacy ◽  
Renal Surgery ◽  
Double Blind ◽  
Bispectral Index Monitoring ◽  
Open Renal Surgery

Comparative Efficacy of Lormetazepam (Noctamid®) and Diazepam (Valium®) in 100 Out-Patients with Insomnia

1981 ◽  
Vol 9 (3) ◽  
pp. 199-202 ◽  
Author(s):  
M Sastre y Hernández ◽  
H-D Hentschel ◽  
K Fichte
Keyword(s):  
Side Effects ◽  
Sleep Disorders ◽  
Blind Study ◽  
Double Blind Study ◽  
Comparative Efficacy ◽  
Double Blind ◽  
Better Than

Lormetazepam (Noctamid®) at a dosage of 1 mg was compared with diazepam (Valium®) at a dosage of 5 mg in a 7-day double-blind study. The study involved fifty patients in the lormetazepam group and fifty patients in the diazepam group. All the patients were suffering from sleep disorders as a concomitant symptom of general diseases. Lormetazepam was significantly better than diazepam in the: Reduction of the time taken to fall asleep (p < 0.05) Prolongation of the duration of uninterrupted sleep (p < 0.05) Reduction of the frequency of awakening (p < 0.05) Lormetazepam displayed no hang-over effects or other side-effects and, in this respect too, was significantly superior to diazepam (p < 0.05).

Clinical Evaluation of Three-Day Treatment of Vaginal Mycosis with Clotrimazole Vaginal Tablets

1983 ◽  
Vol 11 (3) ◽  
pp. 179-185 ◽  
Author(s):  
Shigemitsu Mizuno ◽  
Nankun Cho
Keyword(s):  
Treatment Group ◽  
Effective Treatment ◽  
Clinical Evaluation ◽  
Clinical Assessment ◽  
Adverse Reactions ◽  
Therapy Group ◽  
Day Treatment ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind

A double-blind study was conducted comparing a 3-day (200 mg once a day for 3 consecutive days) treatment with a 6-day (100 mg once a day for 6 consecutive days) treatment of clotrimazole inpatients with vaginal mycoses. Two days after therapy, fungal eradication was achieved in 87·7% of the patients who received 3-day therapy and 89·1% of patients who received 6-day therapy. With regard to the clinical assessment, 2 days after therapy the symptoms had disappeared in 54·4%, improved in 42·1%, were unchanged in 1·8%, and aggravated in 1·8% of the 3-day therapy group. The corresponding values in the 6-day group were 63·6%, 34·5%, 1·8% and 0%. Reappearance of fungi was found 2 weeks after therapy in 15·6% of the 3-day treatment group and 8·7% of the 6-day treatment group. No adverse reactions were seen in either group which necessitated the discontinuation of therapy. There were no statistical differences between any of the above results and it is therefore concluded that 3-day clotrimazole therapy is an effective treatment for primary vaginal mycosis.

Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study

1983 ◽  
Vol 11 (suppl B) ◽  
pp. 205-214 ◽  
Author(s):  
N. N. Huang ◽  
J. Palmer ◽  
H. Keith ◽  
D. Schidlow ◽  
S. Braverman ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Blind Study ◽  
Double Blind Study ◽  
Comparative Efficacy ◽  
Double Blind ◽  
Tolerance Study
Sign in / Sign up

Export Citation Format

Share Document